The Association between Dietary Insulin Index and Load with Gastric Cancer in Afghanistan-Reference-Cited by-同舟云学术

The Association between Dietary Insulin Index and Load with Gastric Cancer in Afghanistan

Published:2021-12-13 Issue: Volume: Page:1-10
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Amiry Freshta¹²,Barekzai Ahmad Mujtaba¹,Aminianfar Azadeh¹,Esmaillzadeh Ahmad¹³⁴

Affiliation:

1. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

2. Department of Public Health Management, School of Public Health, Kabul University of Medical Sciences, Kabul, Afghanistan

3. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

4. Food Security Research Center, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2021.2014906

Reference41 articles.

1. Global cancer statistics, 2012

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Epidemiology of Stomach Cancer

4. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

5. Demographic Profile of Gastric Cancer in Afghanistan

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary insulin indices and low-carbohydrate diet and the odds of colorectal cancer: a case-control study;European Journal of Cancer Prevention;2023-12-18

2. Cancer prevalence, incidence, and mortality rates in Afghanistan in 2020: A review study;Cancer Reports;2023-08-13

3. LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer;Bioengineered;2022-03-24